Pediatric Infectious Disease
What they do most for Medicare patients
| Service, sort | Times billed, sort |
|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 470 |
| Established patient office or other outpatient visit, 30-39 minutes | 457 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 313 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 187 |
| Established patient office or other outpatient visit, 40-54 minutes | 166 |
| Adm sarscv2 bvl 30mcg/.3ml a | 163 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 96 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 89 |
| Established patient office or other outpatient visit, 20-29 minutes | 86 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 56 |
| Insertion of needle into vein (3 years or older) | 37 |
| Adm sarscv2 bvl 50mcg/.5ml a | 30 |
| New patient office or other outpatient visit, 45-59 minutes | 18 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 16 |
| Administration of influenza virus vaccine | 14 |
| Telephone medical discussion with physician, 21-30 minutes | 12 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 12 |
← Back to Pediatric Infectious Disease
Sources: Medicare Care Compare (hospitals and schools; Medicare-enrolled clinicians), CMS Medicare Physician & Other Practitioners 2023 (services), Medicare Part D Prescribers 2024 (drugs).